Gastric Cancer' Textbook Oncological Outcome and Tumor Board Performance
Recruiting now
Conditions studied: Stomach Neoplasm
In brief
The goal of this observational, no-profit, spontaneous, retrospective, monocentric study is to compare surgical and oncologic outcomes in patients affected by gastric cancer before and after the institution of the Tumor Board, a multidisciplinary weekly case discussion. The main question it aims to answer is whether the Textbook Outcome (TO) and Textbook Oncological Outcome (TOO) of patients with non-early, non-metastatic gastric cancer undergoing surgical treatment with curative intent have improved before (from January 2018 to November 2019) and after (from December 2019 onwards) the establishment of the Multidisciplinary Tumor Board (MTB) at Fondazione Policlinico Gemelli (FPG).
Key facts
- Study ID
- NCT06923449
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- People needed
- 250
- Starts
- 2024-05-16
- Expected to finish
- 2025-06-30
- Last updated by the study team
- 2025-04-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- pathology-confirmed diagnosis of gastric adenocarcinoma
- age 18 years or older
- surgical candidates with curative intent
You may not qualify if…
- Endoscopic Mucosal Resection (EMR) or Endoscopic Submucosal Dissection (ESD)
- previous EMR or ESD (salvage surgery)
- histologies other than adenocarcinoma (no squamous cell carcinomas, GISTs, sarcomas, lymphomas, etc)
- unsufficient staging (unclear clinical stage at diagnosis)
- emergency presentation (obstrucetd, significantly bleeding, perforated gastric cancer)
- synchronous tumors affecting survival
- pregnant patients
- age <18years
Where it is running
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS — Rome, IT, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.